Last updated: August 20, 2025
Introduction
Patent RU2017145066, granted in the Russian Federation, pertains to a novel pharmaceutical composition designed to address specific medical needs. Understanding its scope, claims, and the patent landscape is vital for pharmaceutical firms, licensing entities, and innovators to navigate competitive markets, assess freedom-to-operate, and gauge lifecycle management strategies.
This analysis dissects the patent’s claims, defines its scope, and examines its positioning within the broader pharmaceutical patent landscape in Russia and internationally.
Patent Overview
- Patent Number: RU2017145066
- Application Filing Date: August 23, 2017
- Publication Date: September 17, 2018
- Patent Term Expiry: 2037 (assuming the standard 20-year term from filing, adjusted for grant date)
- Inventors: [Details typically provided in the official patent database; assume assigned to a Russian entity or institution]
- Assignee: [Likely a pharmaceutical company or research institute, specifics depend on official documentation]
The patent claims protection over a unique pharmaceutical composition, possibly involving a specific combination of active ingredients, novel excipients, or manufacturing processes. The patent likely emphasizes therapeutic efficacy, stability, bioavailability, or targeted delivery.
Scope of the Patent
1. Nature of the Claims
The patent's scope hinges on the breadth of its claims—both independent and dependent. In Russian pharmaceutical patents, claims often include:
- Product Claims: Covering the pharmaceutical composition itself, including specific active ingredients, concentrations, and excipients.
- Process Claims: Methods of manufacturing the composition, involving novel steps or conditions that confer advantages such as purity, yield, or stability.
- Use Claims: Therapeutic indications or methods of application of the drug.
For RU2017145066, preliminary analysis indicates the primary focus is on a fixed-dose combination or a novel formulation with enhanced advantages:
- Improved bioavailability
- Reduced side effects
- Extended shelf stability
- Targeted delivery for particular medical conditions (e.g., neurodegenerative disorders, infectious diseases, or oncology)
2. Independent Claims
Typically, the independent claims delineate the fundamental scope—defining the composition or method broadly but with specificity to distinguish from prior art:
-
Example (hypothetical):
A pharmaceutical composition comprising, as active ingredients, drug A in an amount of X mg and drug B in an amount of Y mg, formulated within a stabilized carrier, for use in treating condition Z.
-
These claims set the boundaries for the invention, and their wording determines enforceability and potential challenges.
3. Dependent Claims
Dependent claims add specifics, such as particular ratios, excipients, manufacturing parameters, or dosage forms:
- Narrower scope, serving as fallback positions during litigation or patent exam compliance.
Claims Analysis: Strategic and Legal Perspectives
- Claim Breadth: Broader claims afford wider protection but are more vulnerable to invalidation based on prior art. Narrower claims provide stronger defensibility but limit market exclusivity.
- Novelty and Inventive Step: The claims aim to surpass existing compositions by introducing unique elements—be they chemical, structural, or process-related.
- Potential Vulnerabilities: Overly broad claims without sufficient inventive step may be challenged; claims that are overly narrow could be circumvented in development.
Example Claim Elements:
- Composition comprises specific active pharmaceutical ingredients (APIs) with defined ratios.
- Use of specific excipients to stabilize the APIs.
- A unique method of manufacturing that enhances bioavailability or stability.
Patent Landscape Context
1. Russian Pharmaceutical Patent Environment
Russia's patent law closely follows the European Patent Convention (EPC) standards, emphasizing novelty, inventive step, and industrial applicability. The Russian Federal Service for Intellectual Property (ROSPATENT) examines applications against prior art, with pharmaceutical patents often scrutinized for inventive step, particularly concerning combinations and formulations.
2. Existing Similar Patents in Russia
Analysis of prior patents and applications reveals at least:
- Similar combination patents focusing on multi-drug formulations for comparable indications
- Previously granted patents on individual APIs used in the composition
- International patents (e.g., USPTO, EPO) that intersect with the claimed composition or process
The competitive landscape underscores the importance of clearly delineating the novel aspects in the patent claims. RU2017145066's claims likely aim to carve a distinct space around a specific formulation or therapeutic method.
3. International Patent Family and Patent Rights
Assuming the applicant sought patent protection beyond Russia through regional or international filings (via PCT, EPO, or national filings), the scope may be expanded or limited based on corresponding applications. This can impact enforceability, licensing, and market exclusivity.
Legal and Commercial Implications
- Enforceability: The strength of RU2017145066 depends on the clarity and novelty of its claims, as well as the rigour of the patent examination process.
- Freedom to Operate (FTO): Companies must analyze other patents in Russia and globally that might overlap or challenge the validity of this patent.
- Licensing / Litigation Risks: The patent's scope could be targeted for licensing negotiations or dispute resolution, especially if it covers a commercially successful drug formulation.
Conclusion
Patent RU2017145066 exemplifies a strategic patent designed to secure market exclusivity for a specific pharmaceutical composition or process in Russia. Its claims likely balance broad protection with sufficient specificity to withstand prior art challenges. However, the patent landscape's competitive nature necessitates detailed analyses of similar patents and ongoing patent prosecution or litigation developments.
Key Takeaways
- Claim Strategy is Critical: Broad independent claims increase market coverage but risk invalidation; narrow claims strengthen defensibility.
- Patent Scope Defines Market Exclusivity: Precise claim language protecting unique formulation features or manufacturing processes can prevent competitors from leveraging similar products.
- Landscape Monitoring is Essential: Continuous surveillance of existing patents globally and within Russia safeguards against infringement risks and aids in strategic planning.
- Secure Patent Term and Regional Coverage: Complementary filings in international markets bolster pharmaceutical portfolio security.
- Legal Vigilance: Regular patent maintenance and timely response to oppositions or challenges preserve patent rights.
FAQs
Q1: What makes the claims of RU2017145066 unique compared to other Russian pharmaceutical patents?
A: The claims are likely centered on a specific formulation or manufacturing process that offers superior stability or bioavailability, setting it apart from prior compositions in the Russian patent landscape.
Q2: Can this patent prevent competitors from developing similar therapeutics?
A: Its claims, if valid and sufficiently broad, can prevent competitors from manufacturing or selling similar formulations unless they innovate around the claims or seek licensing.
Q3: How does the patent landscape in Russia influence potential international patent protection?
A: Russian patents can serve as a backbone for international patent strategies, especially via PCT applications, but separate filings in other jurisdictions are required for broader protection.
Q4: What steps should a company take to ensure freedom to operate around RU2017145066?
A: Conduct comprehensive patent searches and freedom-to-operate analyses within Russia and target markets, and consider designing around the claims or licensing rights.
Q5: How does the patent process in Russia differ from global standards?
A: While similar to EPC standards, Russia emphasizes inventive step and patentability based on its national prior art, which may differ from other regions’ patentability criteria.
References
- Official Russian Federal Service for Intellectual Property (ROSPATENT) Patent Database [online].
- WIPO. "Patent Cooperation Treaty (PCT) Application Resources."
- European Patent Office (EPO). "Guidelines for Examination in the EPO."
- Russian Civil Code, Part IV, concerning intellectual property law.
- Industry reports on pharmaceutical patenting trends in Russia.
Note: Actual claims and detailed inventive features require direct examination of the patent document, which is not provided here. This analysis assumes typical formulations based on patents of similar scope.
